Showing results (1971-1980 of 2,088) with videos related to

Sort By:
Pageof 209
BMJ Open|December 22, 2022
Cohort profile: Biomarkers related to folate-dependent one-carbon metabolism in colorectal cancer recurrence and survival - the FOCUS ConsortiumBiljana Gigic, Eline van Roekel, Andreana N Holowatyj, et al.
Wiener Klinische Wochenschrift|May 14, 2024
[Interdisciplinary, collaborative D-A-CH (Germany, Austria and Switzerland) consensus statement concerning the diagnostic and treatment of myalgic encephalomyelitis/chronic fatigue syndrome]Kathryn Hoffmann, Astrid Hainzl, Michael Stingl, et al.
Blood|November 17, 2011
A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32Wendy Cozen, Dalin Li, Timothy Best, et al.
American Journal of Hematology|February 7, 2025
Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort StudySamuel Yamshon, Jean L Koff, Melissa C Larson, et al.
Gut|October 3, 2023
HLA-DPA1*02:01~B1*01:01 is a risk haplotype for primary sclerosing cholangitis mediating activation of NKp44+ NK cellsBritta F Zecher, David Ellinghaus, Sebastian Schloer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2018
Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical TrialsMatthew J Maurer, Hervé Ghesquières, Brian K Link, et al.
Nature Communications|August 8, 2024
Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulationMatthew E Stokes, Kerstin Wenzl, C Chris Huang, et al.
BMC Cancer|January 8, 2020
Comprehensive assessments and related interventions to enhance the long-term outcomes of child, adolescent and young adult cancer survivors - presentation of the CARE for CAYA-Program study protocol and associated literature reviewJ Salchow, J Mann, B Koch, et al.
The British Journal of Nutrition|February 6, 2020
One-carbon metabolites, B vitamins and associations with systemic inflammation and angiogenesis biomarkers among colorectal cancer patients: results from the ColoCare StudyRama Kiblawi, Andreana N Holowatyj, Biljana Gigic, et al.
Blood|June 5, 2014
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomesEdgardo R Parrilla Castellar, Elaine S Jaffe, Jonathan W Said, et al.
Pageof 209